Edition:
India

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

18.37USD
15 Dec 2017
Change (% chg)

$0.98 (+5.64%)
Prev Close
$17.39
Open
$17.61
Day's High
$18.97
Day's Low
$17.34
Volume
1,796,160
Avg. Vol
229,817
52-wk High
$33.20
52-wk Low
$10.83

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.44 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.86 1.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5 8.56 15.40 6.10 6.76
Quarter Ending Mar-18 2 6.25 7.50 5.00 --
Year Ending Dec-17 6 27.23 34.80 22.00 21.78
Year Ending Dec-18 6 35.92 54.00 23.70 32.85
Earnings (per share)
Quarter Ending Dec-17 5 -0.44 -0.28 -0.50 -0.30
Quarter Ending Mar-18 2 -0.54 -0.52 -0.55 --
Year Ending Dec-17 5 -1.69 -1.53 -1.75 -1.20
Year Ending Dec-18 5 -2.08 -1.52 -2.64 -1.26

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5.88 7.32 1.44 24.44
Quarter Ending Jun-17 5.82 5.92 0.09 1.58
Quarter Ending Mar-17 5.30 6.22 0.91 17.26
Quarter Ending Dec-16 6.10 5.63 0.47 7.75
Quarter Ending Sep-16 4.54 4.87 0.33 7.22
Earnings (per share)
Quarter Ending Sep-17 -0.50 -0.44 0.06 -11.29
Quarter Ending Jun-17 -0.41 -0.45 0.03 -8.43
Quarter Ending Mar-17 -0.34 -0.36 0.02 -5.88
Quarter Ending Dec-16 -0.22 -0.31 0.09 -38.83
Quarter Ending Sep-16 -0.22 -0.22 0.00 -2.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 8.56 8.56 8.56 8.77 6.76
Quarter Ending Mar-18 6.25 6.25 6.25 6.25 --
Year Ending Dec-17 27.23 27.24 27.24 26.01 21.78
Year Ending Dec-18 35.92 35.91 35.91 36.29 32.85
Earnings (per share)
Quarter Ending Dec-17 -0.44 -0.44 -0.44 -0.46 -0.30
Quarter Ending Mar-18 -0.54 -0.54 -0.54 -0.51 --
Year Ending Dec-17 -1.69 -1.69 -1.69 -1.78 -1.20
Year Ending Dec-18 -2.08 -2.08 -2.08 -2.06 -1.26

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 1 0 1
Year Ending Dec-18 1 0 1 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0